NYSE - Delayed Quote USD

Pediatrix Medical Group, Inc. (MD)

7.31 -0.15 (-2.01%)
At close: May 28 at 4:00 PM EDT
7.31 0.00 (0.00%)
After hours: May 28 at 6:01 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. James D. Swift M.D. CEO & Director 1.21M -- 1962
Mr. C. Marc Richards Executive VP & CFO 850.33k -- 1971
Dr. Curtis B. Pickert M.D. Executive VP & COO 850.17k -- 1958
Ms. Mary Ann E. Moore Executive VP, General Counsel & Secretary 808.3k -- 1961
Mr. Lee A. Wood Executive Vice President of National & Market Operations 652.01k -- 1969
Mr. John C. Pepia Senior VP & Chief Accounting Officer 931.2k -- 1963
Ms. Cheryl M. VanPatten Senior VP & Chief Information Officer -- -- --
Mr. Daniel Patrick Corcoran Senior Vice President of Administration & Managed Care -- -- --
Mr. Charles W. Lynch C.F.A. Senior VP of Finance, Strategy & Investor Relations -- -- --
Ms. Meghan K. Lublin Senior VP, Chief Brand & Communications Officer -- -- --

Pediatrix Medical Group, Inc.

1301 Concord Terrace
Sunrise, FL 33323
United States
954 384 0175 https://www.pediatrix.com
Sector: 
Healthcare
Full Time Employees: 
5,450

Description

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Corporate Governance

Pediatrix Medical Group, Inc.’s ISS Governance QualityScore as of May 1, 2024 is 1. The pillar scores are Audit: 2; Board: 3; Shareholder Rights: 1; Compensation: 2.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 1, 2024 at 12:30 PM UTC - August 5, 2024 at 12:30 PM UTC

Pediatrix Medical Group, Inc. Earnings Date

Recent Events

May 9, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 7, 2024 at 1:00 PM UTC

Q1 2024 Earnings Call

May 7, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 25, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 28, 2024 at 12:00 AM UTC

DEFA14A: Proxy Statements

February 20, 2024 at 2:00 PM UTC

Q4 2023 Earnings Call

February 20, 2024 at 12:00 AM UTC

10-K: Periodic Financial Reports

February 15, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

February 14, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

January 22, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

Related Tickers